These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9131099)

  • 1. [Therapy and prevention of recurrence in bladder cancer. Convincing results].
    Urologe A; 1995 Sep; 34(5 Suppl):1-4. PubMed ID: 9131099
    [No Abstract]   [Full Text] [Related]  

  • 2. [The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy].
    Matveev BP; Kariakin OB; Safiullin KN; Figurin KM; Levi DT; Vatin OE
    Urol Nefrol (Mosk); 1993; (5):27-9. PubMed ID: 8310581
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
    García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; González Alvarez RC; Jalón Monzón A; Martínez Gómez FJ; Sánchez Trilla A; Regadera Sejas J
    Arch Esp Urol; 2007; 60(1):36-43. PubMed ID: 17408170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of recurrence in urinary bladder cancer--quo vadis?].
    Kriegmair M
    Fortschr Med; 1989 Mar; 107(8):14-5. PubMed ID: 2707703
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokines.
    Videira PA; Calais FM; Correia M; Ligeiro D; Crespo HJ; Calais F; Trindade H
    Urology; 2009 Oct; 74(4):944-50. PubMed ID: 19428084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravesical BCG therapy for superficial bladder cancer].
    Segawa N; Iwamoto Y; Azuma H; Yamamoto K; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The intravesical administration of BCG vaccine in treating recurrent superficial bladder cancer].
    Panteleeva ES; Neprina GS; Vatin OE; Kariakin OB; Safiullin KN
    Urol Nefrol (Mosk); 1997; (2):29-32. PubMed ID: 9206879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Topical immunotherapy with BCG in the adjuvant treatment of superficial bladder tumors--15-year-experience].
    Geavlete P; Georgescu D; Arabagiu I
    Chirurgia (Bucur); 2000; 95(2):157-68. PubMed ID: 14768319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG].
    Shekarsarai H; Zlotta AR; Drowart A; Van Vooren JP; De Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K
    Acta Urol Belg; 1997 Mar; 65(1):1-4. PubMed ID: 9245197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BCG Immunotherapy Against Non-Muscle Invasive Bladder Cancer: Recent Results, Current Studies and Future Perspectives].
    Takeuchi A; Shiota M; Tatsugami K; Yokomizo A; Eto M
    Fukuoka Igaku Zasshi; 2016 Jan; 107(1):8-11. PubMed ID: 27333654
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intravesical instillation in the treatment of superficial tumors of the bladder].
    Chopin DK
    Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2].
    Wen R; Zhou G; Xie S; Lian B; Sun X; Chen J
    Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):247-8. PubMed ID: 11825381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Agrawal et al.: The safety and efficacy of different doses of bacillus Calmette-Guérin in superficial bladder transitional cell carcinoma. (Urology 2007;70:1075-1078).
    Simone G; Leonardo C; Gallucci M
    Urology; 2008 Nov; 72(5):1187-8. PubMed ID: 18774592
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial.
    Inman BA
    J Urol; 2006 May; 175(5):1960; author reply 1960-1. PubMed ID: 16600806
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
    Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y
    Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-adapted use of intravesical immunotherapy.
    Braasch MR; Böhle A; O'Donnell MA
    BJU Int; 2008 Nov; 102(9 Pt B):1254-64. PubMed ID: 19035890
    [No Abstract]   [Full Text] [Related]  

  • 18. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials.
    Han RF; Pan JG
    Urology; 2006 Jun; 67(6):1216-23. PubMed ID: 16765182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
    Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y;
    Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.